Evidence map›Paper›PMID 37387624›Full record

ArticleAnnals of the American Thoracic Society2023

Strategies to Assess the Effect of Continuous Positive Airway Pressure on Long-Term Clinically Important Outcomes among Patients with Symptomatic Obstructive Sleep Apnea: An Official American Thoracic Society Workshop Report.

Lucas M Donovan, Camilla M Hoyos, R John Kimoff, Mary J Morrell, Nicholas A Bosch, David M Chooljian, R Doug McEvoy, Amy M Sawyer, Todd H Wagner, Rasha R Al-Lamee and 13 more

Abstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Long-term health outcomes for patients with obstructive sleep apnea: placing the Agency for Healthcare Research and Quality report in context-a multisociety commentary.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Lucas M Donovan
Camilla M Hoyos
R John Kimoff
Mary J Morrell
Nicholas A Bosch
David M Chooljian
R Doug McEvoy
Amy M Sawyer
Todd H Wagner
Rasha R Al-Lamee
David Bishop
Margaret A Carno
Matt Epstein
Mark Hanson
Mary S M Ip
Marie Létourneau
Sushmita Pamidi
Sanjay R Patel
Jean-Louis Pépin
Naresh M Punjabi
Susan Redline
J Daryl Thornton
Susheel P Patil

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Using Lay Health Advisors to Help African American Patients Address the Social Context of HypertensionU54MD002265 · NIMHD · CASE WESTERN RESERVE UNIVERSITY · PI SEHGAL, ASHWINI · 2017 to 2021
$7.1M
Redesigning Medical specialty Outpatient DELivery through virtual SLEEP care (REMODEL-SLEEP)IK2HX002816 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI DONOVAN, LUCAS MATTHEW · 2020 to 2024
–
HSRD VA IK2 HX002816NCATS NIH HHS UL1 TR002548NIMHD NIH HHS U54 MD002265
6 · The paper itself

Abstract

Continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnea (OSA). Although CPAP improves symptoms (e.g., daytime sleepiness), there is a lack of high-quality evidence that CPAP prevents many long-term outcomes, including cognitive impairment, myocardial infarction, and stroke. Observational studies suggest that patients with symptoms may be particularly likely to experience these preventive benefits with CPAP, but ethical and practical concerns limited the participation of such patients in prior long-term randomized trials. As a result, there is uncertainty about the full benefits of CPAP, and resolving this uncertainty is a key priority for the field. This workshop assembled clinicians, researchers, ethicists, and patients to identify strategies to understand the causal effects of CPAP on long-term clinically important outcomes among patients with symptomatic OSA. Quasi-experimental designs can provide valuable information and are less time and resource intensive than trials. Under specific conditions and assumptions, quasi-experimental studies may be able to provide causal estimates of CPAP's effectiveness from generalizable observational cohorts. However, randomized trials represent the most reliable approach to understanding the causal effects of CPAP among patients with symptoms. Randomized trials of CPAP can ethically include patients with symptomatic OSA, as long as there is outcome-specific equipoise, adequate informed consent, and a plan to maximize safety while minimizing harm (e.g., monitoring for pathologic sleepiness). Furthermore, multiple strategies exist to ensure the generalizability and practicality of future randomized trials of CPAP. These strategies include reducing the burden of trial procedures, improving patient-centeredness, and engaging historically excluded and underserved populations.

Indexed as

Cognitive DysfunctionMyocardial InfarctionSleep Apnea, ObstructiveContinuous Positive Airway PressureHumansInformed ConsentCPAPOSAquasi-experimental studiesrandomized clinical trialsresearch ethics

Identifiers

PMID37387624
PMCPMC12039958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.